Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38797
Full metadata record
DC FieldValueLanguage
dc.contributor.authorConrad, Nathalie-
dc.contributor.authorVERBEKE, Geert-
dc.contributor.authorMOLENBERGHS, Geert-
dc.contributor.authorGoetschalckx, Laura-
dc.contributor.authorCallender, Thomas-
dc.contributor.authorCambridge, Geraldine-
dc.contributor.authorMason, Justin C.-
dc.contributor.authorRahimi, Kazem-
dc.contributor.authorMcMurray, John J., V-
dc.contributor.authorVerbakel, Jan Y.-
dc.date.accessioned2022-10-24T09:08:51Z-
dc.date.available2022-10-24T09:08:51Z-
dc.date.issued2022-
dc.date.submitted2022-10-14T15:44:04Z-
dc.identifier.citationLANCET, 400 (10354) , p. 733 -743-
dc.identifier.urihttp://hdl.handle.net/1942/38797-
dc.description.abstractBackground Some autoimmune diseases are associated with an increased risk of cardiovascular disease. We aimed to determine whether or not this is true, and to what extent, for a broad range of autoimmune conditions. Methods In this population-based study, we used linked primary and secondary care records from the Clinical Practice Research Datalink (CPRD), GOLD and Aurum datasets, to assemble a cohort of individuals across the UK who were newly diagnosed with any of 19 autoimmune diseases between Jan 1, 2000, and Dec 31, 2017, younger than 80 years at diagnosis, and free of cardiovascular diseases up to 12 months after diagnosis. We also assembled a matched cohort with up to five individuals matched on age, sex, socioeconomic status, region, and calendar year, who were free of autoimmune disease and free of cardiovascular diseases up to 12 months after study entry. Both cohorts were followed up until June 30, 2019. We investigated the incidence of 12 cardiovascular outcomes and used Cox proportional hazards models to examine differences in patients with and without autoimmune diseases. Findings Of 22 009 375 individuals identified from the CPRD databases, we identified 446 449 eligible individuals with autoimmune diseases and 2 102 830 matched controls. In the autoimmune cohort, mean age at diagnosis was 46middot2 years (SD 19 center dot 8), and 271 410 (60 center dot 8%) were women and 175 039 (39 center dot 2%) were men. 68 413 (15 center dot 3%) people with and 231 410 (11 center dot 0%) without autoimmune diseases developed incident cardiovascular disease during a median of 6 center dot 2 years (IQR 2 center dot 7-10 center dot 8) of follow-up. The incidence rate of cardiovascular disease was 23 center dot 3 events per 1000 patient -years among patients with autoimmune disease and 15 center dot 0 events per 1000 patient-years among those without an autoimmune disease (hazard ratio [HR] 1 center dot 56 [95% CI 1 center dot 52-1 center dot 59]). An increased risk of cardiovascular disease with autoimmune disease was seen for every individual cardiovascular disease and increased progressively with the number of autoimmune diseases present (one disease: HR 1 center dot 41 [95% CI 1 center dot 37-1 center dot 45]; two diseases: 2 center dot 63 [2 center dot 49-2 center dot 78]); three or more diseases: 3middot79 [3 center dot 36-4 center dot 27]), and in younger age groups (age < 45 years: 2 center dot 33 [2 center dot 16-2 center dot 51]; 55-64 years: 1 center dot 76 [1 center dot 67-1 center dot 85]; >= 75 years: 1 center dot 30 [1 center dot 24-1 center dot 36]). Among autoimmune diseases, systemic sclerosis (3 center dot 59 [2 center dot 81-4 center dot 59]), Addison's disease (2 center dot 83 [1 center dot 96-4 center dot 09]), systemic lupus erythematosus (2 center dot 82 [2 center dot 38-3 center dot 33]), and type 1 diabetes (2 center dot 36 [2 center dot 21-2 center dot 52]) had the highest overall cardiovascular risk. Interpretation These findings warrant targeted cardiovascular prevention measures, in particular in younger patients with autoimmune diseases, and further research into pathophysiological mechanisms underlying these complications. Copyright (c) 2022 Elsevier Ltd. All rights reserved.-
dc.description.sponsorshipHorizon 2020 Marie Skłodowska-Curie Actions and European Society of Cardiology. This project has received funding from the EU’s Horizon 2020 research and innovation programme under the Marie SkłodowskaCurie grant (agreement number 843267). NC is further supported by a grant from the European Society of Cardiology (grant number App000037070). KR is supported by the British Heart Foundation (grant reference PG/18/65/33872 and FS/19/36/34346), the Oxford Martin School, the National Institute for Health Research Oxford Biomedical Research Centre, and UK Research & Innovation’s Global Challenge Research Fund (grant reference ES/P011055/1). TC is supported by the Wellcome Trust as a Wellcome Clinical PhD Training Fellow. JYV is supported by the National Institute for Health and Care Research Community Healthcare MedTech and In Vitro Diagnostics Co-operative at Oxford Health NHS Foundation Trust. JJVM is supported by a British Heart Foundation Centre of Research Excellence grant (RE/18/6/34217). The views expressed here are those of the authors and not necessarily those of the funders. We thank Hilary Shepherd, Sonia Coton, and Eleanor L Axson from the CPRD for their support in preparing the dataset underlying these analyses. Justin Mason died shortly before publication of this work. He was widely recognised as an outstanding clinician and academic, a gifted leader, and a friend to many. Justin was an international authority on large vessel vasculitis and his care for his patients and contributions to the vasculitis community will continue to make a significant difference for many years to come.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.rights2022 Elsevier Ltd. All rights reserved.-
dc.subject.otherFemale-
dc.subject.otherHeart Disease Risk Factors-
dc.subject.otherHumans-
dc.subject.otherMale-
dc.subject.otherMiddle Aged-
dc.subject.otherRisk Factors-
dc.subject.otherUnited Kingdom-
dc.subject.otherCardiovascular Diseases-
dc.subject.otherDiabetes Mellitus, Type 1-
dc.titleAutoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK-
dc.typeJournal Contribution-
dc.identifier.epage743-
dc.identifier.issue10354-
dc.identifier.spage733-
dc.identifier.volume400-
local.format.pages11-
local.bibliographicCitation.jcatA1-
dc.description.notesConrad, N (corresponding author), Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium.-
dc.description.notesnathalie.conrad@kuleuven.be-
local.publisher.placeSTE 800, 230 PARK AVE, NEW YORK, NY 10169 USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.type.programmeH2020-
local.relation.h2020843267-
dc.identifier.doi10.1016/S0140-6736(22)01349-6-
dc.identifier.pmid36041475-
dc.identifier.isi000860483700016-
dc.contributor.orcidVerbeke, Geert/0000-0001-8430-7576; Verbakel, Jan/0000-0002-7166-7211;-
dc.contributor.orcidConrad, Nathalie/0000-0001-5027-5481-
local.provider.typewosris-
local.description.affiliation[Conrad, Nathalie; Goetschalckx, Laura; Verbakel, Jan Y.] Katholieke Univ Leuven, Acad Ctr Gen Practice, Dept Publ Hlth & Primary Care, EPI Ctr, Leuven, Belgium.-
local.description.affiliation[Verbeke, Geert; Molenberghs, Geert] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSta, Leuven, Belgium.-
local.description.affiliation[Verbeke, Geert; Molenberghs, Geert] Katholieke Univ Leuven, Leuven, Belgium.-
local.description.affiliation[Callender, Thomas] UCL, Dept Resp Med, London, England.-
local.description.affiliation[Cambridge, Geraldine] UCL, Dept Rheumatol, Div Med, London, England.-
local.description.affiliation[Mason, Justin C.] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, London, England.-
local.description.affiliation[Rahimi, Kazem] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Deep Med, Oxford, England.-
local.description.affiliation[Verbakel, Jan Y.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.-
local.description.affiliation[McMurray, John J., V] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow City, Scotland.-
local.description.affiliation[Conrad, Nathalie] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium.-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.fullcitationConrad, Nathalie; VERBEKE, Geert; MOLENBERGHS, Geert; Goetschalckx, Laura; Callender, Thomas; Cambridge, Geraldine; Mason, Justin C.; Rahimi, Kazem; McMurray, John J., V & Verbakel, Jan Y. (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. In: LANCET, 400 (10354) , p. 733 -743.-
item.accessRightsOpen Access-
item.validationecoom 2023-
item.contributorConrad, Nathalie-
item.contributorVERBEKE, Geert-
item.contributorMOLENBERGHS, Geert-
item.contributorGoetschalckx, Laura-
item.contributorCallender, Thomas-
item.contributorCambridge, Geraldine-
item.contributorMason, Justin C.-
item.contributorRahimi, Kazem-
item.contributorMcMurray, John J., V-
item.contributorVerbakel, Jan Y.-
crisitem.journal.issn0140-6736-
crisitem.journal.eissn1474-547X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Autoimmune diseases and cardiovascular risk_ a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK.pdf
  Restricted Access
Published version2.69 MBAdobe PDFView/Open    Request a copy
Autoimmune.pdfPeer-reviewed author version1.46 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.